Characterization of Induction of Protooncogene c-<i>myc</i> and Cellular Growth in Human Vascular Smooth Muscle Cells by Insulin and IGF-I
Nirmal K. Banskota(Brigham and Women's Hospital), George L. King(Joslin Diabetes Center), Philip Olsen(Brigham and Women's Hospital), Karen Zellner(Brigham and Women's Hospital), Rebecca Taub(Madrigal Pharmaceuticals (United States))
Cited by 134
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells.
|Proceedings of the National Academy of Sciences|1982|1.4k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k